Author
Listed:
- Ye Xu
(University of Miami
University of Miami)
- Na Man
(University of Miami
University of Miami)
- Daniel Karl
(University of Miami
University of Miami)
- Concepcion Martinez
(University of Miami
University of Miami)
- Fan Liu
(University of Miami
University of Miami)
- Jun Sun
(University of Miami
University of Miami)
- Camilo Jose Martinez
(University of Miami
University of Miami)
- Gloria Mas Martin
(University of Miami
University of Miami)
- Felipe Beckedorff
(University of Miami
University of Miami)
- Fan Lai
(University of Miami
University of Miami)
- Jingyin Yue
(University of Miami
University of Miami)
- Alejandro Roisman
(University of Miami
University of Miami)
- Sarah Greenblatt
(University of Miami
University of Miami)
- Stephanie Duffort
(University of Miami)
- Lan Wang
(University of Miami
University of Miami
Shanghai Jiao Tong University School of Medicine)
- Xiaojian Sun
(University of Miami
University of Miami
Shanghai Jiao Tong University School of Medicine)
- Maria Figueroa
(University of Miami
University of Miami)
- Ramin Shiekhattar
(University of Miami
University of Miami)
- Stephen Nimer
(University of Miami
University of Miami
University of Miami)
Abstract
AML1-ETO (AE) is a fusion transcription factor, generated by the t(8;21) translocation, that functions as a leukemia promoting oncogene. Here, we demonstrate that TATA-Box Binding Protein Associated Factor 1 (TAF1) associates with K43 acetylated AE and this association plays a pivotal role in the proliferation of AE-expressing acute myeloid leukemia (AML) cells. ChIP-sequencing indicates significant overlap of the TAF1 and AE binding sites. Knockdown of TAF1 alters the association of AE with chromatin, affecting of the expression of genes that are activated or repressed by AE. Furthermore, TAF1 is required for leukemic cell self-renewal and its reduction promotes the differentiation and apoptosis of AE+ AML cells, thereby impairing AE driven leukemogenesis. Together, our findings reveal a role of TAF1 in leukemogenesis and identify TAF1 as a potential therapeutic target for AE-expressing leukemia.
Suggested Citation
Ye Xu & Na Man & Daniel Karl & Concepcion Martinez & Fan Liu & Jun Sun & Camilo Jose Martinez & Gloria Mas Martin & Felipe Beckedorff & Fan Lai & Jingyin Yue & Alejandro Roisman & Sarah Greenblatt & S, 2019.
"TAF1 plays a critical role in AML1-ETO driven leukemogenesis,"
Nature Communications, Nature, vol. 10(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12735-z
DOI: 10.1038/s41467-019-12735-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12735-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.